Drug
EMB-01
EMB-01 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(20%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Other(3)
Detailed Status
unknown3
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 14 (80.0%)
Phase 21 (20.0%)
Trials by Status
recruiting120%
not_yet_recruiting120%
unknown360%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_1
EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
NCT07649655
recruitingphase_1
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NCT05176665
unknownphase_1
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
NCT05498389
unknownphase_1
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
NCT03797391
unknownphase_2
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
NCT04868253
Clinical Trials (5)
Showing 5 of 5 trials
NCT07649655Phase 1
EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
NCT05176665Phase 1
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NCT05498389Phase 1
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
NCT03797391Phase 1
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
NCT04868253Phase 2
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5